We also intend that this public declaration will increase hospital accountability to MRF users that the data is complete as of the date indicated in the file
Comment: A few commenters question the legal validity of CMS using MUC as the basis of payment, and some of those commenters believe that radiopharmaceutical manufacturers are required to report ASP by statute
Although SCD is rare, its symptoms typically begin with sensory disturbances in the hands, followed by reduced vibration sense, ataxic gait, and pathological reflexes such as hyperreflexia and a positive Babinski sign [4]
When to seek medical advice: Persistent or worsening injection site reactions (increasing redness, warmth, or discharge suggesting infection) Severe or persistent headaches Chest pain or palpitations Unexplained muscle weakness or cramps New or worsening neurological symptoms despite treatment Unexpected bleeding or bruising For non-emergency concerns, contact your GP or NHS 111
Inject slowly intravenously